Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All News Releases
        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Hamburger menu
    • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
    • Create a Free Account
      • ALL CONTACT INFO
      • Contact Us


        11AM ET Sunday – 8PM ET Friday

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Why PRWeb
    • Contact
      • Send a Release
      • Sign up
      • Log in
      • Resources
      • RSS
      • GDPR
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Sign up
      • Log in
      • Resources
      • RSS
      • GDPR
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Laboratories Confirm Role of Infection in Morgellons Disease


      News provided by

      The Charles E. Holman Morgellons Disease Foundation

      Jun 15, 2016, 06:00 ET

      Share this article

      Share this article


      A cultured spirochete from a Morgellons subject’s skin seen with darkfield microscopy.   Photo Credit: Marianne Middelveen.
      A cultured spirochete from a Morgellons subject’s skin seen with darkfield microscopy. Photo Credit: Marianne Middelveen.

      Austin, TX. (PRWEB) June 15, 2016 -- Until recently, Morgellons disease was widely believed in the medical community to be a delusional illness. However, with research support from The Charles E. Holman Morgellons Disease Foundation (CEHMDF), this opinion has been challenged due to two new supportive studies presented at the recent CEHMDF annual meeting in Austin, TX.

      “Collectively, the research into Morgellons disease clearly shows a bacterial, infective process in these patients,” said Dr. Randy Wymore of Oklahoma State University-Center for Health Sciences, an author of one of the studies.

      Collectively, the research into Morgellons disease clearly shows a bacterial, infective process in these patients, said Randy S.Wymore, PhD

      Post this

      Morgellons disease is a multi-system illness characterized by the formation of unusual, sometimes brightly colored fibers within skin. It is a debilitating, painful and life impacting condition. In addition to slowly healing skin lesions, an array of multi-system symptoms can occur, including fatigue, joint and muscle pain, intestinal problems and neurological symptoms including behavioral changes. Patients with Morgellons disease may shed unusual particles from the skin described as fibers, “sand” or seed-like black specks, or crystallized particles.

      The cause of Morgellons disease has been the topic of heated debate. Many medical professionals believe that the disease is not a true somatic illness and maintain that it is the result of delusional beliefs. In 2013 an international group of scientists contradicted this theory, finding Borrelia spirochetes (corkscrew-shaped bacteria associated with tick-borne disease) in skin samples of 4 patients (1) followed by a larger study in 2015 (2). Despite this evidence the medical community at large has been slow to acknowledge the association between Morgellons disease and Borrelia infection.

      Two additional laboratories have now replicated this important research. Oklahoma State University-Center for Health Sciences research team led by Randy S. Wymore, PhD reported finding Borrelia DNA in Morgellons skin samples. Dr. Wymore’s presentation at the recent medical conference, Multiple Bacterial Species Identified in Morgellons Samples, provided much anticipated results and independent corroboration of previously reported findings.

      Additionally, IGeneX Laboratory found DNA from three different species of Borrelia in patient skin specimens (3,4). Independent laboratory confirmation detecting Borrelia in Morgellons skin specimens is an important step in proving that Morgellons disease is a true somatic illness rather than the result of delusional beliefs. Independent confirmation also shows that the initial findings of Borrelia infection are reproducible if the right detection methods are used. “Multiple papers have shown a connection between Borrelia burgdorferi and Morgellons disease. Data in publication from multiple researchers indicates the presence of more than one variety of Borrelia species, and our data indicates the presence of other unusual bacteria in Morgellons samples. Collectively, the research into Morgellons disease clearly shows a bacterial, infective process in these patients. In contrast, and despite the bombastic claims of some, there is zero convincing, scientific evidence that Morgellons is a psychogenic illness, “said, Dr. Wymore.

      The research discovery and continued conclusive substantiation of bacterial involvement in Morgellons disease have given the CEHMDF renewed determination to fulfill its mission of discovering the cause and a cure for this complex disease. “We have taken the first baby steps to understand Morgellons disease”, says Cindy Casey-Holman, RN, director of the Holman Foundation. “Now we need a few medical leaps to cure it.”

      About The Charles E. Holman Morgellons Disease Foundation
      The Charles E. Holman Morgellons Disease Foundation, based in Austin, TX, is a 501(c) (3) nonprofit organization committed to advocacy and philanthropy in the battle against Morgellons. Director, Cindy Casey-Holman, RN, leads the foundation, named for her husband, Charles E. Holman, a pioneer in the fight against MD.

      The CEHMDF is the recognized authority and primary funding source for Morgellons Disease medical-scientific research. There are neither grants, nor any other public or private funding to support research for Morgellons. Donations are tax deductible in the US. To learn more about Morgellons Disease go to http://www.MorgellonsDisease.org.

      References:

      1. Middelveen MJ, Burugu D, Poruri A, et al. Association of spirochetal infection with Morgellons disease. F1000Research. 2013; 2:25. doi:10.12688/f1000research.2-25.v1.
      2. Middelveen, Marianne J et al. “Exploring the Association between Morgellons Disease and Lyme Disease: Identification of Borrelia Burgdorferi in Morgellons Disease Patients.” BMC Dermatology 15.1 (2015): 1. PMC. Web. 12 June, 2016.
      3. Wymore, PhD, Randy S. et al. "The Investigation Of The Microbial And Molecular Analysis Of Morgellons Epithelial Tissue Samples." 2015. Poster Presentation. Retrieved 12 June 2016, from http://www.thecehf.org/resources/OSU%20_2015%20_Research.pdf
      4. Shah, PhD, Jyotsna S. "Morgellons Disease – Chronic Form Of Borrelia Infection?”. 2016. Presentation. Retrieved 12 June 2016, from http://www.thecehf.org/jyotsna-s-shahphd.html

      Gwen Simmons, RN, PHN-B, The Charles E. Holman Morgellons Disease Foundation, http://www.thecehf.org, +1 (901) 252-7494, [email protected]

      Modal title

      Contact PRWeb

      • 11AM ET Sunday – 8PM ET Friday
      • Contact Us

      About PRWeb

      • About PRWeb
      • Partners
      • Partnership Programs
      • Editorial Guidelines
      • Resources

      Why PRWeb

      • Why PRWeb
      • How It Works
      • Who Uses It
      • Pricing

      Accounts

      • Create a Free Account
      • Log in
      • Contact Us

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Online Member Center
      • ProfNet
      Cision Distribution Helpline
      888-776-0942
      • Legal
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 Cision US Inc.